- Home
- SCM vs AMRN Comparison
SCM vs AMRN Comparison
Compare SCM & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCM | AMRN |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.8M | 339.8M |
| IPO Year | 2012 | 1993 |
Fundamental Metrics
Financial Performance| Metric | SCM | AMRN |
|---|---|---|
| Price | $12.51 | $16.53 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $12.00 |
| AVG Volume (30 Days) | ★ 212.6K | 78.3K |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | ★ 12.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | $102,538,895.00 | ★ $226,733,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.44 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.19 | $7.08 |
| 52 Week High | $15.56 | $20.90 |
Technical Indicators
Market Signals| Indicator | SCM | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 60.12 | 50.35 |
| Support Level | $11.93 | $15.36 |
| Resistance Level | $12.28 | $16.25 |
| Average True Range (ATR) | 0.29 | 0.69 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 96.10 | 58.20 |
Price Performance
Historical ComparisonAbout SCM Stellus Capital Investment Corporation
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.